Gastroenterology
Volume 134, Issue 4 , Pages 945-952 , April 2008

Gastric Cancer Risk in Patients With Premalignant Gastric Lesions: A Nationwide Cohort Study in the Netherlands

  • Annemarie C. de Vries

      Affiliations

    • Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    • Corresponding Author InformationAddress requests for reprints to Annemarie C. de Vries, MD, Department of Gastroenterology and Hepatology, Erasmus MC, Room L-462, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands. fax: (31) 0104632793.
    • ,
  • Nicole C.T. van Grieken

      Affiliations

    • Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Caspar W.N. Looman

      Affiliations

    • Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    • ,
  • Mariël K. Casparie

      Affiliations

    • Prismant, Utrecht; The Netherlands
    • ,
  • Esther de Vries

      Affiliations

    • Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    • ,
  • Gerrit A. Meijer

      Affiliations

    • Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Ernst J. Kuipers

      Affiliations

    • Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    • Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands

Received 12 September 2007 ,Accepted 10 January 2008.

References 

  1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. 2004;IARC CancerBase No 5 version 2 0, IARCPress, Lyon
  2. Bowles MJ, Benjamin IS. ABC of the upper gastrointestinal tract: cancer of the stomach and pancreas. BMJ. 2001;323:1413–1416December 15
  3. Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S. Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan. Int J Cancer. 2006;118:2315–2321
  4. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735–6740December 15
  5. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;13:784–789345
  6. de Vries AC, Haringsma J, Kuipers EJ. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter. 2007;12:1–15
  7. Fennerty MB. Gastric intestinal metaplasia on routine endoscopic biopsy. Gastroenterology. 2003;125:586–590
  8. Rugge M, Leandro G, Farinati F, et al. Gastric epithelial dysplasia (How clinicopathologic background relates to management). Cancer. 1995;76:376–382
  9. Whiting JL, Sigurdsson A, Rowlands DC, Hallissey MT, Fielding JW. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut. 2002;50:378–381
  10. Siurala M, Lehtola J, Ihamaki T. Atrophic gastritis and its sequelae (Results of 19-23 years’ follow-up examinations). Scand J Gastroenterol. 1974;9:441–446
  11. Casparie M, Tiebosch T, Burger G, et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cellular Oncology. 2007;29:19–24
  12. Cote RA, Robboy S. Progress in medical information management (Systematized nomenclature of medicine (SNOMED)). JAMA. 1980;22:756–762243
  13. Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer. 1985;15:173–17735
  14. Correa P, Haenszel W, Cuello C, et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res. 1990;1:4737–474050
  15. Lamarque D, Levy M, Chaumette MT, et al. Frequent and rapid progression of atrophy and intestinal metaplasia in gastric mucosa of patients with MALT lymphoma. Am J Gastroenterol. 2006;101:1886–1893
  16. Hansson LE, Nyren O, Hsing AW, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 1996;25:242–249335
  17. El-Omar EM, Oien K, Murray LS, et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H pylori. Gastroenterology. 2000;118:22–30
  18. Kato I, Vivas J, Plummer M, et al. Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela. Cancer Epidemiol Biomarkers Prev. 2004;13:468–476
  19. Kato I, van Doorn LJ, Canzian F, et al. Host-bacterial interaction in the development of gastric precancerous lesions in a high risk population for gastric cancer in Venezuela. Int J Cancer. 2006;119:1666–1671
  20. Kuipers EJ, Perez-Perez GI, Meuwissen SG, et al. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst. 1995;87:1777–1780
  21. Kneller RW, You WC, Chang YS, et al. Cigarette smoking and other risk factors for progression of precancerous stomach lesions. J Natl Cancer Inst. 1992;84:1261–1266
  22. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2003;18(Suppl 2):1–5
  23. Reid BJ. Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterol Clin N Am. 1991;20:817–834
  24. Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL. Natural history of untreated colonic polyps. Gastroenterology. 1987;93:1009–1013
  25. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47:251–255
  26. Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut. 2002;51:130–131
  27. Kokkola A, Haapiainen R, Laxen F, et al. Risk of gastric carcinoma in patients with mucosal dysplasia associated with atrophic gastritis: a follow-up study. J Clin Pathol. 1996;49:979–984
  28. Rugge M, Cassaro M, DiMario MF, et al. The long-term outcome of gastric non-invasive neoplasia. Gut. 2003;52:1111–1116
  29. You WC, Li JY, Blot WJ, et al. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer. 1999;26:615–61983
  30. Kuipers EJ, Haringsma J. Diagnostic and therapeutic endoscopy. J Surg Oncol. 2005;92:203–209
  31. Yao K, Oishi T, Matsui T, et al. Novel magnified endoscopic findings of microvascular architecture in intramucosal gastric cancer. Gastrointest Endosc. 2002;56:279–284
  32. Nakayoshi T, Tajiri H, Matsuda K, Kaise M, Ikegami M, Sasaki H. Magnifying endoscopy combined with narrow band imaging system for early gastric cancer: correlation of vascular pattern with histopathology (including video). Endoscopy. 2004;36:1080–1084
  33. Gotoda T. Endoscopic resection of early gastric cancer. Gastric Cancer. 2007;1–11
  34. Barendregt JJ, Looman CW, Bronnum-Hansen H. Comparison of cohort smoking intensities in Denmark and the Netherlands. Bull World Health Organ. 2002;80:26–32
  35. Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, Wong BC. Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2003;3:1784–179195
  36. Freedman ND, Chow WH, Gao YT, et al. Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women. Gut. 2007;56:1671–1677
  37. Offerhaus GJ, Price AB, Haot J, et al. Observer agreement on the grading of gastric atrophy. Histopathology. 1999;34:320–325
  38. El-Zimaity HM, Ota H, Graham DY, Akamatsu T, Katsuyama T. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer. 2002;1:1428–143694
  39. Bahmanyar S, Zendehdel K, Nyren O, Ye W. Risk of oesophageal cancer by histology among patients hospitalised for gastroduodenal ulcers. Gut. 2007;56:464–468
  40. Leung WK, Lin SR, Ching JY, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut. 2004;53:1244–1249
  41. Mera R, Fontham ET, Bravo LE, et al. Long-term follow-up of patients treated for Helicobacter pylori infection. Gut. 2005;54:1536–1540
  42. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004;14:187–194291
  43. Malfertheiner P, Megraud F, O’Morain C, et al. Current concepts in the management of Helicobacter pylori infection—The Maastricht III Consensus Report. Gut. 2007;56:772–781
  44. Plummer M, Buiatti E, Lopez G, et al. Histological diagnosis of precancerous lesions of the stomach: a reliability study. Int J Epidemiol. 1997;26:716–720

 All authors have contributed to the conception and design and interpretation of the data, and the drafting of the article or critical revision. A.C. de Vries and C.W.N. Looman analyzed the data. The authors have no conflict of interest to disclose.

PII: S0016-5085(08)00177-7

doi: 10.1053/j.gastro.2008.01.071

Gastroenterology
Volume 134, Issue 4 , Pages 945-952 , April 2008

Article Tools

* Image Usage & Resolution